Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Acticor, Antengene, Bonus Biogroup, Frontier, Kyowa Kirin, Nrx, Ose Immunotherapeutics, Qilu, Redhill, Samsung Bioepis, Sesen, Sorrento, Takeda.